
About Araceli Biosciences
Araceli Biosciences is a Healthcare company based in United States founded in 2020. Scientific tools for tissue and cell-based biomarker discovery are developed. Araceli Biosciences has raised $21 million across 5 funding rounds from investors including Bill Cortelyou. Araceli Biosciences offers products and services including Endeavor Automation and Clairvoyance Software. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Assays and Drug Discovery. Its competitors include Lodestone Biomedical, BioAmp Diagnostics and ThinkSense; 1 of its 3 listed competitors has raised funding.
Company details
Developer of scientific tools for tissue and cell-based biomarker discovery drug development. The company is involved in the development of an instrumentation system to improve precision analysis of products by using artificial intelligence. It has developed an endeavor molecular imaging device that helps to identify cell counting, cell cycle, cell differentiation, cell morphology, cell viability, and many more.
- Headquarters United States
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Website aracelibio.com
- Social LinkedIn X YouTube
- Total Equity Funding$21M (USD)
in 5 rounds
- Latest Funding Round$2.53M (USD), Seed
Oct 2026
Products & Services of Araceli Biosciences
Araceli Biosciences offers a comprehensive portfolio of products and services, including Endeavor Automation and Clairvoyance Software.
Hardware for rapid plate scanning in drug discovery processes
Software for advanced image analysis in therapeutic research
Apps and channels of Araceli Biosciences
its YouTube channel Araceli Biosciences has 20 subscribers and 30 videos.
Videos from Araceli Biosciences
The most watched videos on Araceli Biosciences's YouTube channel, Araceli Biosciences (20 subscribers). Click a video to play it here.
More on Araceli Biosciences.
Funding Insights of Araceli Biosciences
Araceli Biosciences has successfully raised a total of $21M across 5 strategic funding rounds. The most recent funding activity was a Seed round of $2.53 million completed in October 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $21M
- Total Rounds 5
- Last Round Seed β $2.53M
- First Round $2.23M
(Apr 2023)
- Investors Count 1
All 5 funding rounds of Araceli Biosciences with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2026 | $2.53M | Series A | β | β | β |
| Oct 2026 | $2.53M | Seed | β | β | β |
| Apr 2025 | $11.2M | Seed | β | Bill Cortelyou | β |
| Dec 2024 | $2.53M | Seed | β | β | β |
| Apr 2023 | $2.23M | Seed | β | β | β |
1 investors in total: 0 institutional and 1 angel.
Investors in Araceli Biosciences
Araceli Biosciences has secured backing from 1 investor, including angel investors. Prominent investors backing the company include Bill Cortelyou.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
BC Bill Cortelyou | unknown_84a76b4daff54b22b |
Investor details for Araceli Biosciences
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Araceli Biosciences
18 people are tracked at Araceli Biosciences (5 in leadership, 13 in team).
| Name | Role | Group |
|---|---|---|
Bill Cortelyou | Chief Executive Officer | Leadership |
Jonathan Day | Vice President WW Sales And Support | Leadership |
Shawn MacDonald | CFO | Leadership |
Scott Igl | Vice President of Engineering | Leadership |
Don Weldon | VP Of Marketing | Leadership |
Kevin Ferguson | Principal Systems Engineer | Team |
Timm Derrickson | Data Scientist–Software Engineer | Team |
Mike Bitsch | Principal Design Engineer | Team |
Swathi Shanbhag | Software Engineer | Team |
Sam Gerendasy | Software Engineering Manager | Team |
Gery Gross | Senior Software Engineer | Team |
Dan Ngo | Software Engineer | Team |
Amanda Clement | Manager, Global Field Applications, Service And Support | Team |
Matt Addington | Manufacturing Engineer | Team |
Matt Boisvert | Application Scientist | Team |
Kristin Halfpenny | Business Development Manager | Team |
Jasmine Silver | Senior Graphic Designer | Team |
Theresa Thompson | Applications Scientist & Engineer | Team |
Complete people profiles for Araceli Biosciences
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Araceli Biosciences
3 dated milestones of Araceli Biosciences across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Araceli Biosciences is founded.
- Funding First funding round of $2.2M.
- Funding Latest funding round, Seed, of $2.5M.
Competitors of Araceli Biosciences
Araceli Biosciences has 3 listed competitors in our database, 1 of them funded. They include Lodestone Biomedical, BioAmp Diagnostics and ThinkSense.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lodestonebiomedical.com | 2015 | Hanover, United States | $1.19M | Provider of magnetic nanoparticle platform technology for in vivo biomarker monitoring in immuno-oncology | ||
| bioampdx.com | 2017 | Berkeley, United States | Developers of diagnostic tests that help to treat patient with a specific antibiotic | |||
| thinksense.com | 2004 | Mclean, United States | Develops sensors for behavioral health data collection and analysis in trials. |
Detailed competitors of Araceli Biosciences
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Araceli Biosciences
The website of Araceli Biosciences (aracelibio.com) receives about 4.4K visits a month.
- Monthly visits4.4K
▼ 11.4% vs previous month
Websites whose visitors overlap most with Araceli Biosciences. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| tricolbiomedical.com | 100% | 1.4K | #10,764,834 | View details | |
| sediabio.com | 93% | 2K | #6,996,278 | View details | |
| otradi.org | 92% | #8,709,976 | View details | ||
| lumencor.com | 91% | 5.5K | #3,662,927 | View details |
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Araceli Biosciences (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Araceli Biosciences
Complete news archive for Araceli Biosciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Araceli Biosciences
Araceli Biosciences was founded in 2020 and raised its 1st funding round 3 years after it was founded.
Araceli Biosciences is headquartered in United States.
Araceli Biosciences is a funded company, having raised a total of $21M across 5 funding rounds to date. The company's 1st funding round was a Seed of $2.23M, raised on Apr 2023.
Developer of scientific tools for tissue and cell-based biomarker discovery drug development. The company is involved in the development of an instrumentation system to improve precision analysis of products by using artificial intelligence. It has developed an endeavor molecular imaging device that helps to identify cell counting, cell cycle, cell differentiation, cell morphology, cell viability, and many more.
Araceli Biosciences's top competitors include Lodestone Biomedical, BioAmp Diagnostics and ThinkSense.
Araceli Biosciences offers Endeavor Automation and Clairvoyance Software.
Araceli Biosciences has 1 investor. Key investors include Bill Cortelyou.
